BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 28070040)

  • 41. Overexpression of miR-664 is associated with enhanced osteosarcoma cell migration and invasion ability via targeting SOX7.
    Bao Y; Chen B; Wu Q; Hu K; Xi X; Zhu W; Zhong X; Chen J
    Clin Exp Med; 2017 Feb; 17(1):51-58. PubMed ID: 26515813
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Impaired cell cycle regulation of the osteoblast-related heterodimeric transcription factor Runx2-Cbfbeta in osteosarcoma cells.
    San Martin IA; Varela N; Gaete M; Villegas K; Osorio M; Tapia JC; Antonelli M; Mancilla EE; Pereira BP; Nathan SS; Lian JB; Stein JL; Stein GS; van Wijnen AJ; Galindo M
    J Cell Physiol; 2009 Dec; 221(3):560-71. PubMed ID: 19739101
    [TBL] [Abstract][Full Text] [Related]  

  • 43. miR-216a inhibits osteosarcoma cell proliferation, invasion and metastasis by targeting CDK14.
    Ji Q; Xu X; Li L; Goodman SB; Bi W; Xu M; Xu Y; Fan Z; Maloney WJ; Ye Q; Wang Y
    Cell Death Dis; 2017 Oct; 8(10):e3103. PubMed ID: 29022909
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Downregulation of microRNA-15a-3p is correlated with clinical outcome and negatively regulates cancer proliferation and migration in human osteosarcoma.
    Shi J; Fu Q; Yang P; Liu H; Ji L; Wang K
    J Cell Biochem; 2018 Jan; 119(1):1215-1222. PubMed ID: 28722268
    [TBL] [Abstract][Full Text] [Related]  

  • 45. MicroRNA-139 inhibits the proliferation and migration of osteosarcoma cells via targeting forkhead-box P2.
    Zhong C; Liu J; Zhang Y; Luo J; Zheng J
    Life Sci; 2017 Dec; 191():68-73. PubMed ID: 28993144
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhibitory roles of miR-320 in osteosarcoma via regulating E2F1.
    Wu H; Li W; Zhang M; Zhu S; Zhang D; Wang X
    J Cancer Res Ther; 2016 Oct; 12(Supplement):68-71. PubMed ID: 27721258
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The cancer-related transcription factor Runx2 modulates cell proliferation in human osteosarcoma cell lines.
    Lucero CM; Vega OA; Osorio MM; Tapia JC; Antonelli M; Stein GS; van Wijnen AJ; Galindo MA
    J Cell Physiol; 2013 Apr; 228(4):714-23. PubMed ID: 22949168
    [TBL] [Abstract][Full Text] [Related]  

  • 48. VEGF-mediated suppression of cell proliferation and invasion by miR-410 in osteosarcoma.
    Zhao D; Jia P; Wang W; Zhang G
    Mol Cell Biochem; 2015 Feb; 400(1-2):87-95. PubMed ID: 25385479
    [TBL] [Abstract][Full Text] [Related]  

  • 49. miR-146b-5p promotes invasion and metastasis contributing to chemoresistance in osteosarcoma by targeting zinc and ring finger 3.
    Xu E; Zhao J; Ma J; Wang C; Zhang C; Jiang H; Cheng J; Gao R; Zhou X
    Oncol Rep; 2016 Jan; 35(1):275-83. PubMed ID: 26549292
    [TBL] [Abstract][Full Text] [Related]  

  • 50. MicroRNA-138 functions as a tumor suppressor in osteosarcoma by targeting differentiated embryonic chondrocyte gene 2.
    Jiang B; Mu W; Wang J; Lu J; Jiang S; Li L; Xu H; Tian H
    J Exp Clin Cancer Res; 2016 Apr; 35():69. PubMed ID: 27095063
    [TBL] [Abstract][Full Text] [Related]  

  • 51. MicroRNA-21 Inhibits the Apoptosis of Osteosarcoma Cell Line SAOS-2 via Targeting Caspase 8.
    Xu B; Xia H; Cao J; Wang Z; Yang Y; Lin Y
    Oncol Res; 2017 Aug; 25(7):1161-1168. PubMed ID: 28109080
    [TBL] [Abstract][Full Text] [Related]  

  • 52. MiR-374a promotes the proliferation of osteosarcoma cell proliferation by targeting Axin2.
    Lu T; Zhang C; Chai MX; An YB; Jia JL
    Int J Clin Exp Pathol; 2015; 8(9):10776-83. PubMed ID: 26617789
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Runx2, p53, and pRB status as diagnostic parameters for deregulation of osteoblast growth and differentiation in a new pre-chemotherapeutic osteosarcoma cell line (OS1).
    Pereira BP; Zhou Y; Gupta A; Leong DT; Aung KZ; Ling L; Pho RW; Galindo M; Salto-Tellez M; Stein GS; Cool SM; van Wijnen AJ; Nathan SS
    J Cell Physiol; 2009 Dec; 221(3):778-88. PubMed ID: 19746444
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Elevated expression of Runx2 as a key parameter in the etiology of osteosarcoma.
    Nathan SS; Pereira BP; Zhou YF; Gupta A; Dombrowski C; Soong R; Pho RW; Stein GS; Salto-Tellez M; Cool SM; van Wijnen AJ
    Mol Biol Rep; 2009 Jan; 36(1):153-8. PubMed ID: 18931939
    [TBL] [Abstract][Full Text] [Related]  

  • 55. MicroRNA-1908 is upregulated in human osteosarcoma and regulates cell proliferation and migration by repressing PTEN expression.
    Yuan H; Gao Y
    Oncol Rep; 2015 Nov; 34(5):2706-14. PubMed ID: 26328886
    [TBL] [Abstract][Full Text] [Related]  

  • 56. MicroRNA-196a overexpression promotes cell proliferation and inhibits cell apoptosis through PTEN/Akt/FOXO1 pathway.
    Shang Y; Wang LQ; Guo QY; Shi TL
    Int J Clin Exp Pathol; 2015; 8(3):2461-72. PubMed ID: 26045752
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Effects of miR-93 on proliferation and apoptosis of osteosarcoma cells].
    Wang RJ; Shi KR; Zhang J; Zhang J; Gao RR; Zhu SC
    Zhonghua Bing Li Xue Za Zhi; 2016 Dec; 45(12):866-870. PubMed ID: 28056303
    [No Abstract]   [Full Text] [Related]  

  • 58. MiR-221 increases osteosarcoma cell proliferation, invasion and migration partly through the downregulation of PTEN.
    Zhu J; Liu F; Wu Q; Liu X
    Int J Mol Med; 2015 Nov; 36(5):1377-83. PubMed ID: 26397386
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [miR-365 inhibits proliferation and promotes apoptosis of SOSP9607 osteosarcoma cells].
    Gao J; Zhao P; Chen X; Wang W; Li Y; Xi W; Zhang W; Hu P; Wang T; Shan L
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Jan; 32(1):44-8. PubMed ID: 26728377
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The downregulation of miR-144 is associated with the growth and invasion of osteosarcoma cells through the regulation of TAGLN expression.
    Zhao M; Huang J; Gui K; Xiong M; Cai G; Xu J; Wang K; Liu D; Zhang X; Yin W
    Int J Mol Med; 2014 Dec; 34(6):1565-72. PubMed ID: 25318625
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.